Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States.
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Yes.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteins.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.
Masitinib mesylate application for conditional approval
Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.
An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination.
Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse.
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis.
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
US and EU regulatory authorities accept oral BG-12 marketing applications for review
Meta-analysis of adverse events in recent randomized clinical trials for dimethil fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.

Pages